Nobel Prize Honors Pioneering Immune System Discoveries

This year's Nobel Prize in Physiology or Medicine was awarded for revolutionary discoveries that illuminate how the immune system targets dangerous infections while sparing the healthy tissues.

Three renowned researchers—Japan's Prof. Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—received this honor.

The work uncovered specialized "sentinels" within the defense system that eliminate rogue immune cells that could attacking the organism.

The findings are now paving the way for innovative therapies for autoimmune diseases and cancer.

The laureates will divide a prize fund valued at 11m SEK.

Crucial Findings

"The research has been decisive for comprehending how the body's defenses operates and why we don't all develop severe autoimmune diseases," commented the chair of the Nobel Committee.

This team's studies explain a core question: In what way does the immune system protect us from numerous invaders while keeping our own tissues unharmed?

The immune system uses immune cells that search for signs of infection, even pathogens and bacteria it has never encountered.

These cells employ sensors—called recognition units—that are produced randomly in a vast number of combinations.

That gives the defense network the capacity to fight a broad range of invaders, but the randomness of the process unavoidably creates white blood cells that can attack the body.

Protectors of the Immune System

Researchers previously understood that a portion of these problematic defense cells were eliminated in the thymus—where immune cells develop.

The latest Nobel Prize recognizes the identification of regulatory T-cells—described as the immune system's "security guards"—which patrol the system to disarm any defenders that attack the body's own tissues.

It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel stated, "The findings have laid the foundation for a novel area of research and spurred the creation of new therapies, for example for tumors and immune disorders."

Regarding cancer, regulatory T-cells prevent the system from fighting the growth, so studies are focused on reducing their quantity.

In self-attack disorders, trials are testing boosting regulatory T-cells so the organism is no longer under attack. A similar approach could also be useful in reducing the chances of transplanted organ failure.

Innovative Studies

Professor Shimon Sakaguchi, of a Japanese institution, performed tests on rodents that had their thymus extracted, causing self-attack conditions.

The researcher demonstrated that injecting defense cells from healthy animals could stop the disease—suggesting there was a system for preventing defenders from attacking the body.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were studying an inherited immune disorder in mice and humans that resulted in the discovery of a genetic factor critical for the way T-regs function.

"The groundbreaking work has revealed how the body's defenses is controlled by T-reg cells, preventing it from mistakenly attacking the healthy cells," commented a leading physiology specialist.

"This work is a remarkable illustration of how basic physiological research can have far-reaching implications for public health."